Search results for "Eczema"

showing 10 items of 30 documents

The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesis

2013

This ISAAC Phase Three synthesis provides summarised information on the main findings of the study, regional tables and figures related to the prevalence and severity of current symptoms of asthma, rhinoconjunctivitis and eczema in the main regions of the world. The large number of surveyed children (≈1,200,000), the large number of centres (233) and countries (98) that participated in ISAAC Phase Three makes this study the most comprehensive survey of these diseases ever undertaken. Globally, the prevalence for current asthma, rhinoconjunctivitis and eczema in the 13-14-year age group was 14.1%, 14.6% and 7.3%, respectively. In the 6-7-year age group the prevalence for current asthma, rhin…

Pulmonary and Respiratory MedicineMalePediatricsmedicine.medical_specialtyAllergyAdolescentInternational CooperationImmunologyEczemaISAACSocioeconomic FactorSurveys and QuestionnairesEpidemiologymedicinePrevalenceHumansImmunology and AllergyPractice Patterns Physicians'ChildSocioeconomic statusChildrenRhinitiAsthmaAsthma; Children; Eczema; ISAAC; Rhinitis; Adolescent; Asthma; Child; Disease Progression; Female; Humans; International Cooperation; Male; Physician's Practice Patterns; Prevalence; Questionnaires; Socioeconomic Factors; Immunology and Allergybusiness.industryQuestionnaireDisease progressionGeneral Medicinemedicine.diseaseAsthmaSocioeconomic FactorsMulticenter studyEtiologyDisease ProgressionLocal environmentFemalePhysician's Practice PatternbusinessDemographyHuman
researchProduct

Rilievi diagnostico-differenziali nell'eczema da contatto

2012

Settore MED/44 - Medicina Del Lavoroezema allergico da contatto eczema professionale patch-test
researchProduct

Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.

2019

Background: Prenatal exposure to perfluoroalkyl substances (PFASs) has been associated with impaired immune and respiratory health during childhood but the evidence is inconsistent and limited for lung function. We studied the association between prenatal PFASs exposure and immune and respiratory health, including lung function, up to age 7 years in the Spanish INMA birth cohort study. Methods: We assessed four PFASs in maternal plasma samples collected during the 1st trimester of pregnancy (years: 2003-2008): perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), and perfluorononanoate (PFNA). Mothers reported the occurrence (yes/no) of lower respir…

SpirometryAdultVital capacityLongitudinal studyRespiratory diseasesEczemaPhysiology010501 environmental sciences01 natural sciences03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePregnancyMedicineHumans030212 general & internal medicineImmune responseChildMaternal-Fetal ExchangeRespiratory Tract Infections0105 earth and related environmental sciencesAsthmaRespiratory SoundsPregnancyFluorocarbonsRespiratory tract infectionsmedicine.diagnostic_testbusiness.industryPublic Health Environmental and Occupational HealthInfantPrenatal exposure delayed effectsmedicine.diseaseAsthmaRespiratory Function TestsPerfluorooctanePerfluoroalkyl substanceschemistryAlkanesulfonic AcidsMaternal ExposureSpainRelative riskChild PreschoolPrenatal Exposure Delayed EffectsEnvironmental PollutantsFemaleCaprylatesbusinessBirth cohortInternational journal of hygiene and environmental health
researchProduct

Adipokines as Biomarkers of Atopic Dermatitis in Adults

2020

Atopic dermatitis (AD) is characterized by chronic, relapsing, pruritic skin inflammation and does not have a well-understood pathogenesis. In this study, we addressed the contribution of adipokines to AD eczema based on the assessment of blood levels of adiponectin, resistin, leptin, lipocalin-2, and vaspin in adult non-obese patients suffering from chronic extrinsic childhood-onset AD. We investigated 49 AD patients with a median age of 37 years. The control group consisted of 30 age-matched healthy subjects. Adipokines were assessed in the serum by ELISA assays and the severity of AD with the SCORing Atopic Dermatitis (SCORAD) index. We found that adiponectin and resistin decreased and l…

adiponectinatopic dermatitispruritisbiomarkerseczemaadipokinesJournal of Clinical Medicine
researchProduct

Probiotics in the prevention and treatment of atopic dermatitis

2020

The use of probiotic supplements might change the composition of the intestinal flora of children, subsequently modulating the immune system's reactivity. The effects of probiotic administration for the prevention/treatment of allergic diseases and atopic dermatitis, in particular, are still so controversial that no definitive recommendation can be made at this stage. Differences in strain specificity, timing, and length of administration all contribute to diversifying the conclusions of this review.

atopic dermatitiallergic diseasesImmunologyEczemaDermatitis Atopiclaw.invention03 medical and health sciencesProbioticSettore MED/38 - Pediatria Generale E Specialistica0302 clinical medicineImmune systemlawFlora (microbiology)HypersensitivitymedicineHumansImmunology and Allergy030212 general & internal medicineChildatopic dermatitisbusiness.industryProbioticsAtopic dermatitismedicine.diseaseinfantStrain specificityallergic disease030228 respiratory systemDietary SupplementsPediatrics Perinatology and Child HealthImmunologyallergic diseases; atopic dermatitis; child; eczema; infant; probioticsbusinessPediatric Allergy and Immunology
researchProduct

Artificial intelligence in the diagnosis of pediatric allergic diseases.

2020

Abstract: Artificial intelligence (AI) is a field of data science pertaining to advanced computing machines capable of learning from data and interacting with the human world. Early diagnosis and diagnostics, self-care, prevention and wellness, clinical decision support, care delivery, and chronic care management have been identified within the healthcare areas that could benefit from introducing AI. In pediatric allergy research, the recent developments in AI approach provided new perspectives for characterizing the heterogeneity of allergic diseases among patients. Moreover, the increasing use of electronic health records and personal healthcare records highlighted the relevance of AI in …

diagnosisChronic care managementImmunologyClinical decision support systemField (computer science)03 medical and health sciencesSettore MED/38 - Pediatria Generale E Specialistica0302 clinical medicinechildrenArtificial IntelligenceHealth careHypersensitivityrespiratory allergyImmunology and AllergyMedicineElectronic Health RecordsHumansRelevance (information retrieval)030212 general & internal medicineChildfood allergybusiness.industryRespiratory allergyallergydiagnosi030228 respiratory systemData qualityPediatrics Perinatology and Child HealtheczemaArtificial intelligencePediatric allergybusinessDelivery of Health CareAlgorithmsPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and ImmunologyREFERENCES
researchProduct

La clinica della dermatite allergica da contatto con diagnostica differenziale

2012

eczema da contatto eczema fotoallergico da contattoSettore MED/44 - Medicina Del Lavoro
researchProduct

Current management of atopic dermatitis and interruption of the atopic march.

2003

Treatment of atopic dermatitis requires a comprehensive approach that includes evaluation of potential triggers and education of the patient and family regarding proper avoidance measures. Hydration of the skin and maintenance of an intact skin barrier remain integral to proper management. Although topical corticosteroids have been a mainstay of anti-inflammatory therapy, the newer topical calcineurin inhibitors offer advantages for treatment of this chronic, relapsing disease. Studies aimed at defining optimal combination therapy and early intervention might change the treatment paradigm for atopic dermatitis.

medicine.medical_specialtyAllergyImmunologyCalcineurin InhibitorsAnti-Inflammatory AgentsDiseaseEczema Area and Severity IndexDermatitis AtopicAtopyPrevalenceImmunology and AllergyMedicineHumansSCORADAsthmamedicine.diagnostic_testbusiness.industryCalcineurinDisease ManagementAtopic dermatitismedicine.diseaseSkin CareDermatologyAsthmabody regionsCalcineurinDisease ProgressionDermatologic AgentsbusinessThe Journal of allergy and clinical immunology
researchProduct

Contact dermatitis caused by iodopropynyl butylcarbamate in Denmark

2013

Iodopropynyl butylcarbamate (IPBC) is a preservative that may cause contact allergy. The first cases were reported in 1997, and IPBC is currently included in our extended European baseline series in Denmark. The authors assess trends during the period 2000-2011 concerning IPBC allergy in Denmark, and address the question of the significance of concomitant reactions to the thiuram mix. Patients/materials/methods Nine thousand seven hundred and fifty-five (6449 female; 3306 male) patients were patch tested with IPBC and the European baseline series at Gentofte Hospital during 2000-2011. The results were registered in an anonymized database, and analyzed with spss™. Fifty-four cases of IPBC co…

medicine.medical_specialtyAllergybusiness.industryDermatologyIodopropynyl butylcarbamatemedicine.diseaseDermatologySurgeryThiuram mixchemistry.chemical_compoundchemistryHand eczemaContact allergyCohortmedicineImmunology and AllergyIn patientbusinessContact dermatitisContact Dermatitis
researchProduct

Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?

2020

medicine.medical_specialtyInterleukin-13Ocular surface diseasebusiness.industryMEDLINEEczemaDermatologyAtopic dermatitismedicine.diseaseAntibodies Monoclonal HumanizedDupilumabDermatologyDermatitis Atopicdupilumab atopic dermatitis ocular surface diseaseInfectious DiseasesmedicineHumansIn patientbusinessJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct